Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 4,313–4,320 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Vyome Holdings Inc. VT-1953 Malignant fungating wounds (MFW) Phase 2 Data Released Oral Wound Care
Wave Life Sciences Ltd. WVE-N531 - (FORWARD-53) Duchenne muscular dystrophy (DMD) in boys NDA Filing Data Released intramuscular Genetic Disorder
Wave Life Sciences Ltd. Suvodirsen (WVE-210201) - DYSTANCE 51 Duchenne muscular dystrophy - Exon 51 Phase 2/3 Trial Discontinued Intravenous Genetic Disorder
Wave Life Sciences Ltd. NHBE GalNAc siRNA (WVE-007) - (INLIGHT) Obesity Phase 2a Trial Planned Intravitreal injection Endocrinology
Whitehawk Therapeutics Inc. FYARRO - (PRECISION 1) Solid tumors Phase 2 Trial Discontinued Intravenous Oncology
Whitehawk Therapeutics Inc. Razuprotafib (AKB-9778) Open-angle glaucoma (OAG) Phase 2 Trial Completed Subcutaneous Opthalmic
Whitehawk Therapeutics Inc. Nab-sirolimus - (AMPECT) Malignant PEComa (Perivascular epithelioid cell tumour) Phase 2 Data Released Intravenous Oncology
Whitehawk Therapeutics Inc. AKB-4924 (GB004) - (SHIFT-UC) Ulcerative Colitis Phase 2 Trial Discontinued Oral Gastroenterology
1…538539540541542…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.